News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Myelin Repair Foundation Launches Its Internship Program Examining the Clinical Drug Development Process in Phase 2 and 3 Clinical Trial Failures


8/30/2012 10:15:09 AM

SARATOGA, Calif.--(BUSINESS WIRE)--The Myelin Repair Foundation (MRF) today announced the launch of its internship program assessing the drug discovery decision-making process in Phase III clinical trial failures. Twenty-six participating graduate students from University of California, Los Angeles will serve as MRF research consultant interns who will apply the comprehensive drug discovery principles established by the Myelin Repair Foundation’s Translational Medicine Platform to 120 drug candidates that previously failed in Phase 2 and 3 trials due to lack of efficacy. Students will acquire in-depth knowledge regarding the clinical drug development process, interact with pharmaceutical industry experts and gain valuable research consulting experience through the MRF Research Consultant Internship program.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES